SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

Direxion Shares ETF Trust - Direxion Daily S&P Biotech Bull 3X ETF

Direxion Daily S&P Biotech Bull 3X Shares

A broad biotech rebound, with traders noting LABUs close tracking of XBI and possible rotation into the sector, is driving attention; some see room for momentum to continue while others warn of a pullback given the ETFs 3x leverage. Traders are also watching inflation data and interest-rate expectations as potential catalysts for rate-sensitive biotech stocks.

Berkshire Hathaway, Inc. is a holding company, which engages in the provision of property and casualty insurance and reinsurance, utilities and energy, freight rail transportation, finance, manufacturing, and retailing services. It operates through the following segments: Insurance, Burlington Northern Santa Fe, LLC (BNSF), Berkshire Hathaway Energy (BHE), Pilot Travel Centers (PTC), Manufacturing, McLane, and Service and Retailing. The Insurance segment includes the underwriting of GEICO, Berkshire Hathaway Primary Group, and Berkshire Hathaway Reinsurance Group. The BNSF segment involves the operation of railroad systems. The BHE segment focuses on regulated electric and gas utility, power generation and distribution, and real estate brokerage activities. The PTC segment consists of managing travel centers and marketing of wholesale fuel. The Manufacturing segment refers to industrial, consumer and building products, home building, and related financial services. The McLane segment covers the wholesale distribution of groceries and non-food items. The Service and Retailing segment relates to the provision of shared aircraft ownership programs, aviation pilot training, electronic components distribution, retailing businesses, automobile dealerships and trailer, and furniture leasing services. The company was founded by Oliver Chace in 1839 and is headquartered in Omaha, NE.

Berkshire Hathaway Inc. - Ordinary Shares - Class B

Berkshires latest quarterly results drew attention for weaker operating performance, particularly in insurance, alongside a sharp increase in share repurchases. Traders are split between viewing the buybacks as a vote of confidence and worrying that softer insurance results and limited investment opportunities could weigh on the outlook.

Algorand (ALGO) is a cryptocurrency launched in 2019. Algorand has a current supply of 10,000,000,000 with 9,078,194,480.417637 in circulation. The last known price of Algorand is 0.09693394 USD and is up 3.39 over the last 24 hours. It is currently trading on 586 active market(s) with $57,858,585.39 traded over the last 24 hours. More information can be found at http://algorand.foundation.

Algorand

Algorands prolonged underperformance and difficulty sustaining rebounds dominate the conversation, with bearish traders warning that rallies may fade and further losses could follow. Bulls counter with accumulation and an expected altcoin recovery, while some point to new leadership and quantum-security or tokenization themes as reasons for optimism.

Direxion Shares ETF Trust - Direxion Daily S&P Biotech Bear 3X ETF

Direxion Daily S&P Biotech Bear 3X Shares

LABD is drawing attention as biotech strength in XBI weighs on the 3x inverse fund, with traders pointing to Moderna-related momentum, acquisition activity and rotation into the sector. Bearish traders are positioning for a pullback, while others argue the rally remains strong and caution that LABDs leverage and daily decay make it difficult to hold through sustained gains in biotech.

Atlassian Corp. is a holding company, which engages in providing team collaboration and productivity software. Its products include Jira Software, Confluence, Jira Service Management, and Loom. The company was founded by Michael Cannon-Brookes and Scott Farquhar in October 2002 and is headquartered in San Francisco, CA.

Atlassian Corporation - Ordinary Shares - Class A

Atlassian Corporation Plc

Atlassians earnings beat was followed by a sharp selloff as traders focused on a slower growth outlook and declining Data Center guidance rather than the backward-looking results. Some see the drop as an overreaction, while others worry that AI adoption and cautious hiring could pressure cloud growth and per-seat demand.

AstraZeneca Plc is a global, science-led biopharmaceutical company focused on the discovery, development, and commercialization of prescription medicines. Its portfolio spans oncology, rare diseases, and biopharmaceuticals, including cardiovascular, renal & metabolism, and respiratory & immunology. The company was founded in 1913 and is headquartered in Cambridge, the United Kingdom.

Astrazeneca plc

AstraZeneca PLC

Reports of AstraZeneca making an acquisition offer for Rhythm Pharmaceuticals are driving attention, with traders weighing the potential expansion into rare metabolic and obesity treatments against uncertainty about whether a deal will proceed or attract other bidders. Some also debate whether AZN should pursue other obesity assets instead.

Revolution Medicines, Inc. is a clinical-stage precision oncology company, which engages in developing novel targeted therapies. It engages in the discovery and development of cancer treatment by pioneering novel combination and monotherapy treatment regimens to maximize the depth and durability of clinical benefit and circumvent adaptive resistance mechanisms for patients which are dependent on the RAS and mTOR pathway. The company was founded by Mark A. Goldsmith, Kevan Shokat, Martin D. Burke, David L. Pompliano and Michael Fischbach in October 2014 and is headquartered in Redwood City, CA.

Revolution Medicines Inc

Attention centers on Revolution Medicines early RASONQUE launch and quarterly update, with traders highlighting rapid uptake and a strong commercial debut. The reaction is divided: some see the launch as evidence of major sales potential, while others worry about whether demand will persist and about high spending; recent buying and call-heavy options activity have added to the bullish chatter.

Invesco Exchange-Traded Fund Trust - Invesco S&P 500 Equal Weight ETF

Invesco S&P 500 Equal Weight ETF

RSP is drawing attention as the equal-weight S&P 500 proxy amid debate over whether leadership is broadening beyond mega-cap tech or concentrating back in a few large stocks. Traders view RSP strength as evidence of healthier participation, while others point to periods of underperformance and weakening breadth as signs the rotation may be faltering.

Corvus Pharmaceuticals, Inc. engages in the development of product candidates for the treatment of cancer and immune-mediated and inflammatory diseases. Its product candidates include soquelitinib, an ITK inhibitor, ciforadenant, an adenosine A2A receptor antagonist, and mupadolimab, a B cell-activating anti-CD73 antibody. The company was founded by Richard A. Miller, Peter A. Thompson, Joseph J. Buggy, and Erik Verner on January 27, 2014 and is headquartered in South San Francisco, CA.

Corvus Pharmaceuticals Inc

Corvus is drawing attention around soquelitinibs clinical pipeline, with investors focused on delayed trial updates and the lack of near-term data, including for PTCL and ALPS. Bulls cite the drugs potential across multiple conditions and institutional interest, while skeptics point to long timelines and limited clinical evidence, fueling debate over the shares volatility.

Select Sector SPDR Trust (The) - State Street Energy Select Sector SPDR ETF

Energy Select Sector SPDR Fund

Oil-price swings tied to uncertainty over the U.S.-Iran conflict and prospects for diplomacy are driving discussion of XLE, with hopes of de-escalation and a retreat in crude weighing on the energy sector. Traders disagree on whether the pullback signals more downside or a buying opportunity given ongoing supply-disruption risks.

statis crypto Watchlist

Bitcoin

Ethereum

Solana

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 
